<DOC>
	<DOCNO>NCT01977170</DOCNO>
	<brief_summary>The objective study know safety Hib/PRP-T vaccine immediate reaction within first 30 minute injection .</brief_summary>
	<brief_title>Safety Hib Vaccine ( Bio Farma )</brief_title>
	<detailed_description>This trial open-label study , randomization , placebo control group . Total 25 young healthy adult ( volunteer ) follow trial . The safety assess within 24 hour , 48 hour , 72 hour , 28 day injection .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adult ( age 18 40 year old ) Provision write informed consent Good health accord clinical investigator Willingness ability adhere regimen study Known enrol study Pregnancy lactation Known suspect allergy vaccine component ( medical history ) History unusual reaction previous vaccination Known suspect immune deficiency , use medication may influence immune system Prior respiratory infection Other vaccination study , one week ( inactivated vaccine ) one month ( live vaccine ) study Acute febrile illness ( temperature &gt; 37.5 Celsius ) Present evidence serious disease demand medical treatment Any significant congenital chronic disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Adults</keyword>
	<keyword>Hib vaccine</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Safety</keyword>
</DOC>